- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07837089
Increasing Engagement With Digital Behavioral Health
Development of a Peer Digital Coach Intervention to Increase Adolescent and Young Adult Cancer Survivors' Engagement With a Digital Behavioral Health Intervention
This is a phased mixed-methods behavioral intervention study that will develop and test Mindful Peer Coach, a peer-supported mindfulness program for adolescent and young adult (AYA) cancer survivors. Phase 1 is a formative qualitative study designed to identify survivor-reported needs and preferences for increasing engagement with a mindfulness meditation app. Phase 2 is a pilot intervention study that will examine the feasibility, acceptability, and preliminary engagement outcomes of the Mindful Peer Coach program using participant surveys, app-use data, peer-coach training, coaching sessions, weekly text-message check-ins, and exit interviews with survivors and coaches.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Gary Kwok, PhD
- Telefonnummer: 2018803057
- E-mail: gary.kwok@hmh-cdi.org
Studiesteder
-
-
New Jersey
-
Nutley, New Jersey, Forenede Stater, 07110
- HMH Center for Discovery and Innovation
-
Kontakt:
- Gary Kwok, PhD
- Telefonnummer: 201-880-3057
- E-mail: gary.kwok@hmh-cdi.org
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- at least one year from treatment completion
- ability to speak conversational English,
- per self-report, not being treated for posttraumatic stress disorder (PTSD), psychosis, or epilepsy/seizures.
- have experience with mindfulness and/or be willing to attend training and supervision sessions (only for coaches)
- at least two years from treatment completion (only for coaches) ;
Exclusion Criteria:
- outside age range
- closer to treatment completion than specified above
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Mindful Peer Coaching
Mindful Peer Coach consists of 1) live virtual and 2) text message coaching. |
Participants will complete six structured weekly videoconference sessions designed to cultivate mindfulness practice and increase engagement with the Happier Meditation app. Each session follows a standardized framework outlined in the training manual to ensure consistency and fidelity. Between sessions, coaches will provide support and accountability via text messaging. The frequency of messages will be determined collaboratively during Session 1. Each exchange begins with a previously tested mindfulness message, followed by tailored responses to reinforce practice, address questions, and sustain engagement. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Minutes use per day (User engagement)
Tidsramme: Minutes used per day will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase
|
Minutes use per day with the mindfulness-based mobile app obtained from the Happier Meditation dashboard. |
Minutes used per day will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase
|
|
Number of days used per week (User engagement)
Tidsramme: Number of days used per week will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase.
|
Number of days used per week with the mindfulness-based mobile app obtained from the Happier Meditation dashboard. |
Number of days used per week will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase.
|
|
Depression
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Depression symptoms will be assessed using the PROMIS Depression measure. PROMIS Depression is an 8-item scale with each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Anxiety
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Anxiety symptoms will be assessed using the PROMIS Anxiety measure. PROMIS Anxiety is an 7-item scale with each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Mindfulness
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Mindfulness will be assessed using the Mindful Attention Awareness Scale measure. Your score falls into a range of 1 to 6, calculated by taking the average of all 15 responses. Higher average scores indicate greater overall mindfulness. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Emotion Regulation
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Emotion Regulation will be assessed using the emotional experience subscale from the Emotion Regulation Questionnaire (ERQ) measure. The Emotion Regulation has 6 items on a 7-point Likert scale, with 1 indicating "strongly disagree" and 7 indicating "strongly agree" ranging from 6 to 42 (computed as the mean of the 6 items). Higher scores indicate a greater tendency to alter how you think about a situation to change its emotional impact. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Positive and Negative Emotions
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Positive and Negative Emotions will be assessed using I-PANAS-SF (International Positive and Negative Affect Schedule Short-Form). It is a 10-item psychological tool that assesses affect. It evaluates both Positive Affect and Negative Affect on two separate 5-item subscales. Each of the 10 emotions is rated on a 5-point Likert scale, resulting in score ranges of 5 to 25 for both the Positive and Negative subscales. Higher scores indicate higher levels of that specific effect. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Distress
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Distress will be assessed using the Perceived Stress Scale. The Perceived Stress Scale (PSS-10) is a 10 item scale that has a total score range from 0 to 40, with higher scores indicating higher levels of perceived stress. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Overall Wellbeing
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Overall Wellbeing will be assessed using the PROMIS Global Health scale. For the standard PROMIS Global Health (PROMIS-GH-10) assessment, the 10 items produce two distinct summary scales: Global Physical Health and Global Mental Health. Because both subscales are made up of 4 items measured on a 1-5 point scale, the raw score range for each subscale is 4 to 20. While raw scores are simply the sum of your responses, they are not used directly to interpret health status. Instead, raw scores are converted into standardized T-scores using an established lookup algorithm: A T-score of 50 represents the average health of the U.S. general population. Every 10 points away from 50 equates to one standard deviation. Higher T-scores indicate better self-reported health, regardless of whether it is the physical or mental subscale. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Sleep Disturbance
Tidsramme: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Sleep Disturbance will be assessed using the PROMIS Sleep Disturbance scale. The raw score range for the PROMIS Sleep Disturbance Scale 4-Item Short Forms: is generally 4 to 20. Higher raw scores correspond to a greater severity of sleep disturbance. These raw scores are then converted into a standardized T-score (where the general U.S. population average is 50, with a standard deviation of 10) using PROMIS Standardized Lookup Tables. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Exit Interview
Tidsramme: At the end of the 8-week intervention period
|
Qualitative feedback collected through semi-structured exit interviews; no quantifiable data will be generated. Themes will be identified and presented using descriptive statistics. |
At the end of the 8-week intervention period
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Gary Kwok, PhD, Hackensack Meridian Health Center for Discovery and Innovation
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- Pro2024-0069
- K01CA308858 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .